Last week’s headlines were dominated by acquisitions across the global dietary supplement universe, with P&G agreeing to acquire Thorne, Kirin snapping up Jamieson Wellness, and Lallemand announcing a deal for BIO-CAT Enzymes & Microbials. Japan’s Kirin Holdings Company has agreed to acquire Jamieson Wellness Inc. for C$2.5 billion (US$1.78 billion), representing a significant step in expanding its Health Science business into North America. The company states it is committed to becoming the most trusted health science company across Asia, Oceania, and North America. Kirin believes Jamieson Wellness is an ideal strategic fit because it brings established brands, strong customer relationships, broad distribution networks, and end-to-end capabilities spanning R&D, manufacturing and sales. Together, Kirin, Blackmores, FANCL and Jamieson Wellness strengthen a global platform now connecting North America, Asia and Oceania.”